Please join us for a day-long, CLE-accredited program discussing risks and opportunities in today’s regulatory environment for pharmaceuticals and other medical products. Whether you are at an established company or an emerging biotech, this program will provide you with a valuable, succinct summation of the important FDA regulatory, pricing, privacy, and compliance issues currently facing our industry today.
Our program will focus around four interactive panels:
• FDA in Focus: Cutting-Edge Quality, Supply Chain, Product Classification, and AdPromo Regulatory Issues
• The Evolving Patient Access Landscape
• Assessing the Impact of the Inflation Reduction Act and Other Key Pricing and Contracting Developments on Your Business
• Emerging Enforcement Themes and Lessons Learned for Compliance and Privacy Programs
A lunchtime discussion will focus on the effect that the recent Supreme Court decisions in Loper Bright, Corner Post, and Jarkesy may have for the life sciences industry, including how companies may need to adapt regulatory and litigation strategies.
Panelists will include:
Gina Cavalier | Partner
Mahnu Davar | Partner, Co-Chair of the Life Sciences & Healthcare Regulatory Practice
Abeba Habtemariam | Partner
Kristin Hicks | Partner
Liz Lindquist | Partner
Jami Vibbert | Partner, Chair of the Privacy, Cybersecurity & Data Strategy Practice
Howard Sklamberg | Partner
We invite you to join the event and come with questions. Please RSVP by September 20, 2024.